🇺🇸 FDA
Pipeline program

Ramelteon

01-02-TL-375-023

Phase 3 small_molecule completed

Quick answer

Ramelteon for Transient Insomnia is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Transient Insomnia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials